Routine Capillary Hemoglobin Testing in United Kingdom Commercial Pilot Applicants

Area of Science:

• Aviation Medicine
• Hematology
• Public Health

Background:

• UK regulations require hemoglobin (Hb) testing for commercial pilot medicals.
• The effectiveness of point-of-care capillary Hb testing for aeromedical certification is unquantified.

Purpose of the Study:

• To evaluate the utility of capillary Hb screening in determining aeromedical certification outcomes for commercial pilot applicants.
• To assess the rate of abnormal capillary Hb levels and their impact on fitness for aviation duty.

Main Methods:

• Retrospective review of UK Civil Aviation Authority Class 1 medical examinations (April 2021-March 2025).
• Identification of applicants with capillary Hb outside established thresholds.
• Analysis of clinical pathways, confirmatory testing, and fitness outcomes.

Main Results:

• 1.43% of 3353 applicants had abnormal capillary Hb (33 high, 15 low).
• Only 3 of 36 applicants with a fitness outcome were unfit or required treatment (8.3% positive predictive value).
• Confirmatory venous testing normalized results for 12 of 13 applicants; no polycythemia cases were identified.

Conclusions:

• Capillary Hb screening demonstrated limited utility in identifying conditions leading to unfitness in asymptomatic pilot applicants.
• The screening did not identify significant issues beyond predeclared conditions or those requiring treatment.
• Further investigation is warranted for serial assessments in established pilots.